BJC Rep

IL10RB expression in cancer cells is associated with evolutionary changes to solidify treatment resistance.

The transcription factor Blimp-1 is suppressed by SLAMF1 and drives Treg cell-mediated immune evasion in non-small cell lung cancer.

转录因子 Blimp-1 受 SLAMF1 抑制，并驱动 Treg 细胞介导的非小细胞肺癌免疫逃逸。

Towards greener and more sustainable pre-clinical oncology research.

迈向更绿色、更可持续的临床前肿瘤学研究

IL-6R expression is an independent prognostic factor in high-grade serous ovarian cancer.

IL-6R表达是高级别浆液性卵巢癌的独立预后因素

The influence of clinical risk factors on the classification of human cancer-associated fibroblasts in PDAC and pancreatitis patients.

临床危险因素对胰腺导管腺癌和胰腺炎患者中人类癌症相关成纤维细胞分类的影响

Single-cell analysis reveals tumour size as a key driver of immune cell profile alterations in primary breast tumours and corresponding lymph nodes.

单细胞分析揭示肿瘤大小是原发性乳腺肿瘤和相应淋巴结中免疫细胞谱改变的关键驱动因素

Primary tumour location, molecular alterations, treatments, and outcome in a population-based metastatic colorectal cancer cohort.

基于人群的转移性结直肠癌队列研究：原发肿瘤位置、分子改变、治疗和预后

Targeting the activated allosteric conformation of the endothelin receptor B in melanoma with an antibody-drug conjugate: mechanisms and therapeutic efficacy

利用抗体-药物偶联物靶向黑色素瘤中内皮素受体 B 的活化变构构象：机制和治疗效果

Temporal evolution and inter-patient heterogeneity in primary and recurrent head and neck squamous cell carcinoma.

Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer.

靶向 PLOD2 可抑制放射复发性前列腺癌的侵袭和转移潜能